Professor, Director of Clinical Research, Radiation Oncology, University of Maryland School of Medicine
Radiation Oncology
Dr. Steven J. Feigenberg, MD
|
|
Give Review
Steven Feigenberg is an expert in the field of Radiation Oncology. He went to Drexel University College of Medicine. Steven Feigenberg is a published doctor. He published 77 publications, including: 'RTOG 9003: The Untold Story.' Steven J. Feigenberg, MD is registered with Medicare.
Publications
- RTOG 9003: The Untold Story.
- Evaluation of template matching for tumor motion management with cine-MR images in lung cancer patients.
- Stereotactic radiotherapy using tomotherapy for early-stage non-small cell lung carcinoma: Analysis of intrafraction tumour motion.
- Audio-visual biofeedback does not improve the reliability of target delineation using maximum intensity projection in 4-dimensional computed tomography radiation thera...
- Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.
- Evaluation of Fractional Regional Ventilation Using 4D-CT and Effects of Breathing Maneuvers on Ventilation.
- Increasing national mastectomy rates for the treatment of early stage breast cancer.
- Dosimetric and geometric evaluation of a novel stereotactic radiotherapy device for breast cancer: The GammaPodâ¢.
- Spatial-Temporal (18)FFDG-PET Features for Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiation Therapy.
- Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer.
- TH-E-217BCD-11: Validation of 4D Computed Tomography (4D-CT) to Evaluate Fractional Regional Ventilation against the Clinical Gold-Standard Scintigraphy V/Q.
- WE-A-217A-06: Can Pre-Chemoradiotherapy FDG PET/CT Identify Residual Metabolically Active Areas Within Individual Esophageal Tumors?
- TU-G-217A-01: Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) for High-Resolution Lung Perfusion Evaluation in Pulmonary Neoplasms Prior to Radiotherapy.
- SU-E-T-403: Delivery Efficiency of StereoArc Stereotactic Body Radiotherapy (SBRT).
- SU-E-T-399: Dosimetric and Geometric Evaluation of a Novel Stereotactic Radiotherapy Device for Breast Cancer: The GammaPod.
- SU-C-217BCD-01: Breathing Maneuvers Result in Regional Changes in Ventilation as Assessed by 4D-CT.
- Accelerated partial breast irradiation via brachytherapy: A patterns-of-care analysis with ASTRO consensus statement groupings.
- Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-a...
- Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.
- Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer.
- Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
- A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.
- Prostate cancer risk assessment program: a 10-year update of cancer detection.
- Radiation-induced tumor after stereotactic radiosurgery for an arteriovenous malformation: case report.
- Intensity-modulated radiotherapy for early larynx cancer: is there a role?
- A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
- The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer.
- Long-term outcomes in breast cancer patients with ten or more positive axillary nodes treated with combined-modality therapy: the importance of radiation field selection.
- Comparing computed tomography localization with daily ultrasound during image-guided radiation therapy for the treatment of prostate cancer: a prospective evaluation.
- A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer.
- Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.
- Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
- Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma?
- Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
- Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy.
- Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and pa...
- What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?
- In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046.
- Androgen suppression plus radiation therapy for prostate cancer.
- A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy.
- Prostate cancer radiotherapy dose response: an update of the fox chase experience.
- Radiation therapy for angiosarcoma.
- Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons.
- Radiation therapy for giant cell tumors of bone.
- Oligodendroglioma: does deferring treatment compromise outcome?
- Angiosarcoma after breast-conserving therapy.
- Celecoxib to decrease urinary retention associated with prostate brachytherapy.
- Whole-lung radiotherapy for giant cell tumors of bone with pulmonary metastases.
- Radiosurgery for paraganglioma of the temporal bone.
- Angiosarcoma after breast-conserving therapy: experience with hyperfractionated radiotherapy.
- Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer.
- Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable n...
- Stereotactic IMRT for prostate cancer: setup accuracy of a new stereotactic body localization system.
- Benefit of three-dimensional image-guided stereotactic localization in the hypofractionated treatment of lung cancer.
- Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily d...
- Esophageal motion during radiotherapy: quantification and margin implications.
- Investigation of optimal beam margins for stereotactic radiotherapy of lung-cancer using Monte Carlo dose calculations.
- Choroidal metastasis from carcinoid tumour: diagnosis by fine-needle biopsy and response to radiotherapy.
- The treatment of non-metastatic prostate cancer with external beam radiation therapy.
- Megavoltage radiotherapy for aneurysmal bone cysts.
- A method for repositioning of stereotactic brain patients with the aid of real-time CT image guidance.
- Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.
- Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
- Palliative radiation therapy.
- Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
- Non-small cell lung cancer clinical practice guidelines in oncology.
- Target localization for post-prostatectomy patients using CT and ultrasound image guidance.
- Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma.
- Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case report.
- Phase I study of radical thoracic radiation, weekly irinotecan, and cisplatin in locally advanced non-small cell lung carcinoma.
- Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).
- Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
- Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation.
- Rectal dose variation during the course of image-guided radiation therapy of prostate cancer.
- Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
- Inadvertent intraarterial injection of ¹â¸F-FDG: a case report and literature review of hot forearm and hot hand signs.
Schools
Hahnemann University
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Cross Blue Shield
- CHAMPVA
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- CoreSource
- Southern Health PPO
- Coventry Health Care of Delaware PPO
- Emblem Health
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Golden Rule
- Choice Care PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Maryland Physicians Care
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Wells Fargo Insurance
Education
-
University of Florida -
Temple University Hospital -
Drexel University College of Medicine
Hospital
-
University of Maryland Medical Center -
University of Maryland Baltimore Washington Medical Center
Drug Facts
| NPI NUMBER | 1790705754 | |
| NPPES Provider LastName | FEIGENBERG | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 212011544 | |
| NPPES Provider State | MD | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 35.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790705754 |
| Last Name Of The Provider | FEIGENBERG |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
|
Dr. Terry J. Styles, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bingchan Zhang, MD |
|
|
Dr. Simeon James K. Yamoah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. O'Connell, MD |
|
|
Dr. Anusha Kalbasi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela J. Boimel, MD |
|
|
Dr. Timothy N. Showalter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric M. Horwitz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nathan D. Jones, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary D. Kao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander Lin, MD |